Full Press Release Details
Media
• January 3, 2024
IRWD Positive Sentiment
Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Key Takeaway: Ironwood Pharmaceuticals is set to present at the 42nd Annual J.P. Morgan Healthcare Conference. This event is a significant platform for companies in the healthcare sector to showcase their innovations and strategies. The conference is expected to enhance Ironwood's visibility among investors and industry stakeholders.
Price reaction · baseline $12.41 (2024-01-02 close) · hit after-hours · 2 other IRWD headline(s) in the window, move may be shared
day 0 close
-0.7%
Market Sentiment Analysis
POSITIVE FACTORS
- Ironwood Pharmaceuticals is participating in a prestigious healthcare conference.
- The presentation may attract investor interest and enhance visibility.
- Participation in the J.P. Morgan Healthcare Conference highlights the company's growth.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)
Frequently Asked Questions
What conference will Ironwood Pharmaceuticals present at?
Ironwood Pharmaceuticals will present at the 42nd Annual J.P. Morgan Healthcare Conference.
When is the J.P. Morgan Healthcare Conference?
The conference is scheduled for January 3, 2024.
Why is this conference significant for Ironwood?
The conference provides a platform to enhance visibility and attract investor interest.